patrick.net

💉💉 The Wall Street Journal ran a startling story yesterday headlined, “Novavax Says FDA Puts Clinical Hold on Covid-19, Flu Vaccines.” Uh oh!

According to Novavax’s mandatory SEC disclosure filed Monday, the FDA paused trials both of Novavax's covid and its standalone flu vaccines, after a trial participant reported nerve damage (motor neuropathy). The stock plunged -24% on the news.

If only the original covid vaccines, approved under EUA, were subject to full clinical trials like Novavax’s new subunit protein vaccine is. I wonder if we’d have discovered more adverse effects, like what’s happening right now. The FDA is trying to recapture its long-lost public trust, but it will take more than this. A lot more.

Northwestern better hurry. Moderna’s stock is down almost 10% just in the last week; and that’s while the rest of the stock market just finished a six-week climbing stretch reaching all-time highs (totally unrelated to government market manipulation in the runup to the election, for ‘national security’).

The University holds a patent on a technology called “lipid nanoparticles,” or LNPs, which are tiny globs of artificial fat encasing the delicate mRNA payload. The LNPs act as a sort of dual preservative and Trojan Horse. Hungry cells are tricked into ‘eating’ the artificial fat globs, which sneak their fake mRNA strands into cells in a process most resembling viral infection.

In fact, scientists even call this type of mRNA delivery “transfection.”

Many heterodox experts who’ve carefully examined the vaccine catastrophe believe LNPs are a separate source of health problems on top of everything we believe about the mRNA itself. So it’s that much more ironic that a new insider fight over the money is developing, over Moderna’s theft of what is inarguably an essential component of the dangerous and ineffective covid shots. The mRNA by itself is useless without the LNP helping it infect victims’ cells.

In fact, scientists even call this type of mRNA delivery “transfection.”